ARCHIVES

In Brief: FDA Cool To Committee Review of INDs; New Commissioner Is Donald Kennedy, Of Stanford

This article is from The Cancer Letter archive.

Vol. 03 No. 10 | March 11, 1977

Download PDF Visit The Full Archive

Related Articles

First CCOP 3 Returns In; Payline Not Yet Determined; Goes to NCAB On Jan. 30

January 26, 1990

Phase III Lung and Pancreatic Cancer Trials Are Stopped

April 30, 2010

Jane Henney Said Tentative Choice For FDA Commissioner

May 22, 1998

Exercise Improves Function, Symptoms Of Cancer Survivors, AHRQ Report Finds

August 27, 2004

In Brief: Satcher Names CDC Director; POG Appoints Monaco To Data Monitoring Committee

September 10, 1993

DCT Board Okays $3 Million In New Programs, $8 Million In Recompetitions

October 24, 1980